LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
---|---|---|---|---|---|---|---|---|---|---|
MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 40.14 | 84.90 | 1720 | 3682 | 0.4671 | 0.7388 | MN20160318_Q02 | L09 |
MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 40.14 | 84.90 | 1817 | 3682 | 0.4935 | 0.7564 | MN20160318_Q02 | L09 |
MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 41.84 | 84.90 | 1858 | 4003 | 0.4641 | 0.7421 | MN20160318_Q02 | L07 |
MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 41.84 | 84.90 | 1948 | 4003 | 0.4866 | 0.7570 | MN20160318_Q02 | L07 |
MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 41.84 | 84.90 | 1786 | 4003 | 0.4462 | 0.7297 | MN20160318_Q02 | L09 |
MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 41.84 | 84.90 | 1871 | 4003 | 0.4674 | 0.7443 | MN20160318_Q02 | L09 |
MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 43.55 | 84.90 | 1963 | 4287 | 0.4578 | 0.7421 | MN20160318_Q02 | L07 |
MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 43.55 | 84.90 | 2053 | 4287 | 0.4788 | 0.7559 | MN20160318_Q02 | L07 |
MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 43.55 | 84.90 | 1878 | 4287 | 0.4380 | 0.7285 | MN20160318_Q02 | L09 |
MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 43.55 | 84.90 | 1949 | 4287 | 0.4545 | 0.7399 | MN20160318_Q02 | L09 |
MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 45.25 | 84.90 | 2084 | 4539 | 0.4591 | 0.7463 | MN20160318_Q02 | L07 |
MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 45.25 | 84.90 | 2143 | 4539 | 0.4720 | 0.7549 | MN20160318_Q02 | L07 |
MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 45.25 | 84.90 | 1985 | 4539 | 0.4372 | 0.7316 | MN20160318_Q02 | L09 |
MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 45.25 | 84.90 | 2031 | 4539 | 0.4474 | 0.7385 | MN20160318_Q02 | L09 |
MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 46.95 | 84.90 | 2181 | 4952 | 0.4404 | 0.7391 | MN20160318_Q02 | L07 |
MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 46.95 | 84.90 | 2227 | 4952 | 0.4497 | 0.7453 | MN20160318_Q02 | L07 |
MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 46.95 | 84.90 | 2042 | 4952 | 0.4123 | 0.7197 | MN20160318_Q02 | L09 |
MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 46.95 | 84.90 | 2089 | 4952 | 0.4218 | 0.7263 | MN20160318_Q02 | L09 |
MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 48.65 | 84.90 | 2128 | 5328 | 0.3993 | 0.7150 | MN20160318_Q02 | L07 |
MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 48.65 | 84.90 | 2293 | 5328 | 0.4303 | 0.7366 | MN20160318_Q02 | L07 |
MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 48.65 | 84.90 | 2127 | 5328 | 0.3992 | 0.7149 | MN20160318_Q02 | L09 |
MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 48.65 | 84.90 | 2188 | 5328 | 0.4106 | 0.7231 | MN20160318_Q02 | L09 |
MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 50.36 | 84.90 | 2312 | 5651 | 0.4091 | 0.7256 | MN20160318_Q02 | L07 |
MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 50.36 | 84.90 | 2402 | 5651 | 0.4251 | 0.7365 | MN20160318_Q02 | L07 |
MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 50.36 | 84.90 | 2215 | 5651 | 0.3920 | 0.7135 | MN20160318_Q02 | L09 |